Experimental drug that targets macrophages, a type of immune cells, in microenvironment surrounding lethal brain tumor glioblastoma multiforme decreased cancer's growth and extended survival of lab mice with cancer. Researcher said results are encouraging for planned clinical trials of drug in combination with radiation therapy in glioma patients.
Fuente : http://www.eurekalert.org/pub_releases/2013-12/asf...
Fuente : http://www.eurekalert.org/pub_releases/2013-12/asf...